Phase II study of amrubicin combined with carboplatin for thymic carcinoma and invasive thymoma north Japan lung cancer group study 0803

Akira Inoue, Shunichi Sugawara, Masao Harada, Kunihiko Kobayashi, Toshiyuki Kozuki, Shoichi Kuyama, Makoto Maemondo, Hajime Asahina, Akiko Hisamoto, Taku Nakagawa, Katsuyuki Hotta, Toshihiro Nukiwa

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of amrubicin combined with carboplatin for thymic carcinoma and invasive thymoma north Japan lung cancer group study 0803'. Together they form a unique fingerprint.

Medicine & Life Sciences